Singapore markets close in 2 hours 19 minutes
Straits Times Index
3,320.22 -6.06 (-0.18%) Nikkei
39,667.07 +493.92 (+1.26%) Hang Seng
18,118.38 +45.48 (+0.25%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,564.52 +415.65 (+0.68%) CMC Crypto 200
1,278.43 -5.35 (-0.42%)
Cyclacel Pharmaceuticals, Inc. (CYCC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.33M |
| Enterprise value | -450.42k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.42 |
| Price/book (mrq) | 0.36 |
| Enterprise value/revenue | 6.10 |
| Enterprise value/EBITDA | 0.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.59 |
| 52-week change 3 | -81.40% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 13.2000 |
| 52-week low 3 | 1.3000 |
| 50-day moving average 3 | 2.0048 |
| 200-day moving average 3 | 3.6140 |
Share statistics
| Avg vol (3-month) 3 | 876.1k |
| Avg vol (10-day) 3 | 73.1k |
| Shares outstanding 5 | 1.46M |
| Implied shares outstanding 6 | 1.46M |
| Float 8 | 1.15M |
| % held by insiders 1 | 7.36% |
| % held by institutions 1 | 22.71% |
| Shares short (15 May 2024) 4 | 145.32k |
| Short ratio (15 May 2024) 4 | 0.07 |
| Short % of float (15 May 2024) 4 | 10.53% |
| Short % of shares outstanding (15 May 2024) 4 | 9.93% |
| Shares short (prior month 15 Apr 2024) 4 | 38.41k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 15 Apr 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 18 Dec 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -15,017.24% |
Management effectiveness
| Return on assets (ttm) | -99.60% |
| Return on equity (ttm) | -496.02% |
Income statement
| Revenue (ttm) | 449k |
| Revenue per share (ttm) | 0.47 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -22.46M |
| Net income avi to common (ttm) | -19.85M |
| Diluted EPS (ttm) | -22.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.8M |
| Total cash per share (mrq) | 1.91 |
| Total debt (mrq) | 21k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.58 |
| Book value per share (mrq) | -1.67 |
Cash flow statement
| Operating cash flow (ttm) | -9.73M |
| Levered free cash flow (ttm) | -6.24M |
© 2024 Yahoo. All rights reserved.